Confronting self-stigma in the schizophrenia spectrum

Background/objectives. Stigma and self-stigma in serious mental illness (SMI) – particularly in schizophrenia – is a crucial, yet poorly researched phenomenon that has a significant effect on the sufferers of the disorder. This article aims to summarize and present recent findings on the topic, the current paradigm surrounding it, as well as any recent approaches suggested in its management and treatment. Methodology. We have selected articles out of the PubMed database, as well as other supporting references, and we have summarized information on three topics: prevalence, impact and suggested approaches. Results. Self-stigma is significantly prevalent globally. The impact is noted in the cited works. The literature suggests a number of approaches on various levels of medical, social and political life. Conclusions. Self-stigma affects approximately one-third of individuals with SMI, with higher rates observed in schizophrenia and variations according to geography and culture. The phenomenon impairs the social function, clinical states and outcomes, and overall quality of life, and it takes place earlier than previously thought. Suggested courses of action include, but are not limited to, various kinds of therapy, community involvement, media and legislative approaches, and more.